Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Sofinnova Partners

Sofinnova Partners Exceeds Target With €165M Biotech Acceleration Fund, Europe’s Largest, With Strong Pharma Support
From Sofinnova Partners
Via Business Wire
Sofinnova Partners Raises €1.2 Billion to Fuel the Next Wave of Life Sciences Innovation
From Sofinnova Partners
Via Business Wire
Sofinnova Welcomes Agnès Pauquet as Head of Human Resources
From Sofinnova Partners
Via Business Wire
Sofinnova Partners appoints Karl Naegler as Partner
From Sofinnova Partners
Via Business Wire
Sofinnova Partners Appoints Two New Partners Strengthening Team of Next Generation Investors
From Sofinnova Partners
Via Business Wire
Sofinnova Partners Portfolio Company Amolyt Pharma to be Acquired by AstraZeneca
From Sofinnova Partners
Via Business Wire
Sofinnova Partners Brings in Dr. Joshua Makower, Stanford Biodesign Co-Founder, as Venture Partner
From Sofinnova Partners
Via Business Wire
Sofinnova Partners Welcomes Andrew M. Weiss as Venture Partner
From Sofinnova Partners
Via Business Wire
Sofinnova Partners and Gustave Roussy forge strategic alliance to boost oncology startup acceleration in France
From Sofinnova Partners
Via Business Wire
Sofinnova Partners Launches Biovelocita, the First Pan-European Investment Strategy Dedicated to the Creation and Acceleration of Biotech Startups
From Sofinnova Partners
Via Business Wire
Sofinnova Partners Unveils Sofinnova.AI: A Cutting-edge Artificial Intelligence Platform Set to Transform Its Life Sciences Investment Practice
From Sofinnova Partners
Via Business Wire
Sofinnova Partners Enhances Leadership in Medtech Acceleration with Key Appointments
From Sofinnova Partners
Via Business Wire
Sofinnova Partners Raises $200M Digital Medicine Fund
From Sofinnova Partners
Via Business Wire
Sofinnova Partners Appoints Mary McCarthy as Partner for the Firm’s Industrial Biotech Strategy
From Sofinnova Partners
Via Business Wire
Sofinnova Partners Launches Digital Medicine Strategy
From Sofinnova Partners
Via Business Wire
Noema Pharma, Founded by Sofinnova Partners, Raises CHF 103 Million (USD 112 Million) in Series B Financing
From Sofinnova Partners
Via Business Wire
Sofinnova Partners Welcomes Mano Iyer as Venture Partner
From Sofinnova Partners
Via Business Wire
Sofinnova Partners Appoints Mats Eklund as Partner and Chief Operating Officer
From Sofinnova Partners
Via Business Wire
AAVantgarde Announces the Appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer
From Sofinnova Partners
Via AccessWire
Topics Stocks
Exposures US Equities
Sofinnova Partners Announces New Investment In Nanophoria, Developer Of An Innovative Non-viral Drug Delivery Platform
From Sofinnova Partners
Via AccessWire
GFBiochemicals raises €15m Series A to Advance its Mission to End Chemical Pollution
From Sofinnova Partners
Via AccessWire
Sofinnova Partners Announces New Investment in Nephris, an Innovative Biotech Targeting Chronic Kidney Diseases
From Sofinnova Partners
Via AccessWire
Gradient Denervation Technologies Announces Appointment of Martin Grasse as Chief Executive Officer
From Sofinnova Partners
Via AccessWire
AAVantgarde Bio appoints Ram Palanki as Chairman of its Board of Directors
From Sofinnova Partners
Via AccessWire
SafeHeal Closes €40 Million Financing Co-Led by Sofinnova Partners and Genesis MedTech To Finance Its Colovac Device Through a Pivotal Clinical Trial in the United States
From Sofinnova Partners
Via AccessWire
Sofinnova Partners Announces a New Investment From Its Medtech Acceleration Fund
From Sofinnova Partners
Via Business Wire
Sofinnova Partners Raises €150M for Its Third Industrial Biotech Fund Dedicated to Environmental Impact
From Sofinnova Partners
Via Business Wire
Geraldine Usseglio Joins Sofinnova Partners as Head of Human Resources
From Sofinnova Partners
Via Business Wire
Sofinnova Partners Congratulates Portfolio Company DNA Script for the Success of Its €142M ($165M) Oversubscribed Series C Fundraise
From Sofinnova Partners
Via Business Wire
Sofinnova Partners Raises €472 ($548) Million to Form Largest Early-Stage Healthcare VC Fund in Europe
From Sofinnova Partners
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.